Enfusion jumps roughly 11% after report of sale exploration

Enfusion shares are on the rise after Reuters’ Milana Vinn reported, citing people familiar with the matter, that the company is in talks with investment bankers to evaluate its options, which could include a potential sale. The software provider for asset managers, which has a market value of $1.1B, decided to interview investment banks in recent weeks after receiving takeover interest from potential suitors, including private equity firms, one of the sources said, according to the report. Shares of Enfusion are up roughly 11% to $9.50 in afternoon trading.